Premium
P2‐006: Exploratory Analyses of Cognitive Effects of Crenezumab in a Mild Alzheimer's Disease Subpopulation of a Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Phase 2 Study (ABBY)
Author(s) -
Mackey Howard,
Cho William,
Ward Michael,
Fang Yuan,
Suliman Shehnaaz,
Ho Carole,
Paul Robert
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1210
Subject(s) - placebo , clinical endpoint , medicine , randomization , statistical significance , randomized controlled trial , gastroenterology , pathology , alternative medicine